{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:03:35Z","timestamp":1794013415607,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,10]],"date-time":"2026-12-10T00:00:00Z","timestamp":1796860800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25K23777"],"award-info":[{"award-number":["JP25K23777"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001697","name":"Keio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jiac.2025.102889","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T23:57:15Z","timestamp":1765238235000},"page":"102889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of epithelial lining fluid drug concentrations to MICi-Based PK\/PD modeling of cefepime\/nacubactam in a murine model of CPE pneumonia"],"prefix":"10.1016","volume":"32","author":[{"given":"Yuki","family":"Mizukami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Muraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Satake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1936-910X","authenticated-orcid":false,"given":"Yuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-1684","authenticated-orcid":false,"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102889_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2025.102889_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jiac.2025.102889_bib3","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/cid\/cix647","article-title":"Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality","volume":"65","author":"Ramirez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102889_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122247","article-title":"The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study","volume":"10","author":"Morimoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2025.102889_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102889_bib6","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib7","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase producing enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1\u201310","key":"10.1016\/j.jiac.2025.102889_bib8","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102889_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/17425250902913808","article-title":"Pharmacokinetics and pharmacodynamics of antimicrobial drugs","volume":"5","author":"Czock","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jiac.2025.102889_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/antibiotics10101179","article-title":"In Vivo pharmacodynamics of \u03b2-Lactams\/Nacubactam against carbapenem-resistant and\/or carbapenemase-producing Enterobacter cloacae and Klebsiella pneumoniae in Murine Pneumonia model","volume":"10","author":"Hagihara","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jiac.2025.102889_bib11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/AAC.06113-11","article-title":"Novel modeling framework to guide design of optimal dosing strategies for \u03b2-lactamase inhibitors","volume":"56","author":"Bhagunde","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jac\/dkad033","article-title":"Development of an optimized and practical pharmacokinetics\/pharmacodynamics analysis method for aztreonam\/nacubactam against carbapenemase-producing K. pneumoniae","volume":"78","author":"Igarashi","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib13","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s11095-023-03608-8","article-title":"In vivo pharmacokinetic\/pharmacodynamic analysis of the efficacy of the cefepime\/nacubactam combination against \u03b2-Lactamase-Producing Enterobacterales based on the instantaneous MIC concept","volume":"40","author":"Igarashi","year":"2023","journal-title":"Pharm Res"},{"key":"10.1016\/j.jiac.2025.102889_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/pulp.1995.1009","article-title":"New concepts in the pulmonary disposition of antibiotics","volume":"8","author":"Bergogne-Berezin","year":"1995","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.jiac.2025.102889_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2958.2005.04941.x","article-title":"Mucin-pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance","volume":"59","author":"Landry","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jiac.2025.102889_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13054-018-2155-1","article-title":"Pharmacokinetics\u2013pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients","volume":"22","author":"V Veiga","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2025.102889_bib17","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014ninth edition","year":"2012"},{"key":"10.1016\/j.jiac.2025.102889_bib18","series-title":"M100: performance standards for antimicrobial susceptibility testing","year":"2025"},{"key":"10.1016\/j.jiac.2025.102889_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11095-022-03425-5","article-title":"Differences in pharmacokinetic\/pharmacodynamic parameters of tedizolid against VRE and MRSA","volume":"40","author":"Liu","year":"2023","journal-title":"Pharm Res"},{"key":"10.1016\/j.jiac.2025.102889_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-4939-8570-8_22","article-title":"Mouse models of acute lung injury and ARDS","volume":"1809","author":"D'Alessio","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jiac.2025.102889_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/19420862.2018.1470727","article-title":"Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs","volume":"10","author":"Larios Mora","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.jiac.2025.102889_bib22","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1093\/jac\/dkv166","article-title":"OP0595, a new diazabicyclooctane: mode of action as a serine \u03b2-lactamase inhibitor, antibiotic and \u03b2-lactam \u201cenhancer.\u201d","volume":"70","author":"Morinaka","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib23","first-page":"104","article-title":"Phase I study 534 of cefepime (BMY-28242) single dose study in healthy Male volunteers","volume":"39","author":"Nakajima","year":"1991","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2025.102889_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02229-19","article-title":"Safety and pharmacokinetic characterization of nacubactam, a novel-lactamase inhibitor, alone and in combination with meropenem, in healthy volunteers","volume":"64","author":"Mallalieu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02382-18","article-title":"Efficacy of human-simulated epithelial lining fluid exposure of meropenem-nacubactam combination against class A serine \u03b2-lactamase-producing Enterobacteriaceae in the neutropenic murine lung infection model","volume":"63","author":"Asempa","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00682-18","article-title":"Plasma and intrapulmonary concentrations of cefepime and zidebactam following intravenous administration of wck 5222 to healthy adult subjects","volume":"62","author":"Rodvold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40262-021-01061-7","article-title":"Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update","volume":"61","author":"Drwiega","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2025.102889_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00006454-200103000-00031","article-title":"Cefepime microbiologic profile and update","volume":"20","author":"Kessler","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2025.102889_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.39.4.812","article-title":"Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins","volume":"39","author":"Satta","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102889_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012458","article-title":"The role of bacterial size, shape and surface in macrophage engulfment of uropathogenic E. coli cells","volume":"20","author":"Peterson","year":"2024","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jiac.2025.102889_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/bmb\/61.1.45","article-title":"Macrophage defences against respiratory tract infections","volume":"61","author":"Gordon","year":"2002","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jiac.2025.102889_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14348\/molcells.2021.0058","article-title":"Development and functions of alveolar macrophages","volume":"44","author":"Woo","year":"2021","journal-title":"Mol Cells"},{"key":"10.1016\/j.jiac.2025.102889_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imm.13143","article-title":"Tissue-resident innate immunity in the lung","volume":"159","author":"Ardain","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.jiac.2025.102889_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1150658","article-title":"Phagocytosis is a primary determinant of pulmonary clearance of clinical Klebsiella pneumoniae isolates","volume":"13","author":"van der Geest","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2025.102889_bib35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood.V99.4.1246","article-title":"Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer","volume":"99","author":"Santosuosso","year":"2002","journal-title":"Blood"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:56:02Z","timestamp":1778594162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25002879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1341321X25002879"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102889","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of epithelial lining fluid drug concentrations to MICi-Based PK\/PD modeling of cefepime\/nacubactam in a murine model of CPE pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102889"}}